Clinical Trial Update: Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial in second-line prostate cancer comparing cabazitaxel/prednisone alone to with custirsen has completed. The document does not include trial results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)
• Custirsen (custirsen)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Achieve Life Sciences | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED